ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
International Journal of Medicinal Mushrooms
インパクトファクター: 1.423 5年インパクトファクター: 1.525 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN 印刷: 1521-9437
ISSN オンライン: 1940-4344

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v18.i1.10
pages 1-7

Effect of the Medicinal Mushroom, Grifola gargal (Agaricomycetes), on Bone Turnover Markers and Serum Lipids in Middle-Aged and Elderly Japanese Women

Etsuko Harada
Department of Immunology, Mie University School of Medicine
Toshihiro Morizono
Iwade Research Institute of Mycology Co. Ltd., Mie, Japan
Toshimitsu Sumiya
Iwade Research Institute of Mycology Co. Ltd., Mie, Japan
Hirokazu Kawagishi
Research Institute of Green Science and Technology, Shizuoka University, Shizuoka, Japan; Graduate School of Agriculture, Shizuoka University, Shizuoka, Japan; and Graduate School of Science and Technology, Shizuoka University, Japan

要約

A clinical study was performed to examine the effect of the edible mushroom, Grifola gargal, on bone turnover markers and serum lipids in middle-aged and elderly Japanese women. Postmenopausal women aged 51−73 years (mean age, 61 years) received daily oral administration of 5 g G. gargal fruiting bodies (hot air-dried and powdered; G. gargal powder [GGP]). Serum levels of bone alkaline phosphatase (BAP) and lipids and urinary deoxypyridinoline (DPD) levels were measured before and 2 weeks after the start of GGP treatment. As a result, urinary DPD bone resorption marker levels in women treated with GGP decreased significantly. Serum levels of the BAP bone formation marker also tended to increase, but the difference was not significant. By contrast, the atherogenic index decreased and the high-density lipoprotein (HDL) ratio increased significantly. However, there were no statistically significant differences in serum lipids of total cholesterol, HDL cholesterol, and low-density lipoprotein cholesterol. In addition, this study demonstrated for the first time that G. gargal is safe for human consumption.


Articles with similar content:

Oral Hypoglycemic Activity of Culinary-Medicinal Mushrooms Pleurotus ostreatus and P. cystidiosus (Higher Basidiomycetes) in Normal and Alloxan-Induced Diabetic Wistar Rats
International Journal of Medicinal Mushrooms, Vol.14, 2012, issue 4
C.A. Wanigatunga, W.J.A.B.N. Jayasuriya, T.S. Suresh, G.H. Fernando, D. Thusitha U. Abeytunga
Carotenoid Lutein Protects the Kidney against Cisplatin-Induced Acute Renal Failure
Journal of Environmental Pathology, Toxicology and Oncology, Vol.32, 2013, issue 1
Ramadasan Kuttan, Edakkadath Raghavan Sindhu
Insulin Protects against Brain Oxidative Stress with an Apparent Effect on Episodic Memory in Doxorubicin-Induced Cognitive Dysfunction in Wistar Rats
Journal of Environmental Pathology, Toxicology and Oncology, Vol.36, 2017, issue 2
Rekha S. Shenoy, Anoop Kishore, Krishnadas Nandakumar, Grandhi Venkata Ramalingayya, Sri Pragnya Cheruku, Nitesh Kumar, Vishwajeet Sonawane, Pawan G. Nayak
MT-α-Glucan from the Fruit Body of the Maitake Medicinal Mushroom Grifola frondosa (Higher Basidiomyetes) Shows Protective Effects for Hypoglycemic Pancreatic β-Cells
International Journal of Medicinal Mushrooms, Vol.15, 2013, issue 4
Hong Lei, Shuzhen Guo, Qin Wang, Hanju Sun, Juncheng Han, Wutong Wu, Minmin Zhang
Protective Effects of Extract from Sclerotium of the King Tuber Medicinal Mushroom, Pleurotus tuberregium (Higher Basidiomycetes) on Carbon Tetrachloride-Induced Hepatotoxicity in Wistar Albino Rats
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 12
Christopher C. Osubor, Chidube A. Alagbaoso, Omoanghe S. Isikhuemhen